Amesite (AMST)
Market Price (12/28/2025): $2.12 | Market Cap: $9.7 MilSector: Information Technology | Industry: Application Software
Amesite (AMST)
Market Price (12/28/2025): $2.12Market Cap: $9.7 MilSector: Information TechnologyIndustry: Application Software
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -19% | Weak multi-year price returns2Y Excs Rtn is -57%, 3Y Excs Rtn is -108% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -3.3 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1725% |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 69% | Expensive valuation multiplesP/SPrice/Sales ratio is 50x | |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -55% | Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -13% | |
| Megatrend and thematic driversMegatrends include Artificial Intelligence, and Cloud Computing. Themes include AI Software Platforms, AI in Education, Show more. | Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 120% | |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1231%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1396% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -39% | ||
| High stock price volatilityVol 12M is 104% | ||
| Key risksAMST key risks include [1] a material going concern risk due to consistent losses and less than a year of cash runway, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -19% |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 69% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -55% |
| Megatrend and thematic driversMegatrends include Artificial Intelligence, and Cloud Computing. Themes include AI Software Platforms, AI in Education, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -57%, 3Y Excs Rtn is -108% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -3.3 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1725% |
| Expensive valuation multiplesP/SPrice/Sales ratio is 50x |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -13% |
| Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 120% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1231%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1396% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -39% |
| High stock price volatilityVol 12M is 104% |
| Key risksAMST key risks include [1] a material going concern risk due to consistent losses and less than a year of cash runway, Show more. |
Why The Stock Moved
Qualitative Assessment
AI Analysis | Feedback
Here are five key points highlighting why Amesite (AMST) stock moved by approximately -23.2% between August 31, 2025, and December 28, 2025:
<b>1. Deteriorating Financial Performance with Mounting Losses:</b>
Amesite reported significant losses and high expenses during this period. For example, Q3 2025 earnings announced on September 30, 2025, showed a loss of -$642.3k, a 30.5% decrease from the previous quarter. The operating revenue was around $94,000, while total expenses exceeded $750,000, contributing to mounting losses. Q4 2025 earnings, posted on October 24, 2025, also reported an EPS of -$0.14.
<br><br>
<b>2. Receipt of Nasdaq Deficiency Letter:</b>
Amesite received a Nasdaq deficiency letter for non-compliance, which can raise concerns among investors regarding the company's ability to meet listing requirements and its overall financial stability.
<br><br>
<b>3. Bearish Market Sentiment and Technical Sell Signals:</b>
Towards the end of the specified period, technical analyses indicated a strong bearish sentiment for AMST stock. On December 23, 2025, the stock fell by 6.96% and was down by 11.57% over the preceding 10 days, with technical indicators issuing "sell" signals and downgrading the stock from a "Sell" to a "Strong Sell" candidate.
<br><br>
<b>4. Inability of Positive Announcements to Sustain Stock Growth:</b>
Despite several positive announcements, such as a 69% quarter-over-quarter revenue increase on October 30, 2025, and plans for an AI-powered EMR platform, along with 63% revenue growth from NurseMagicâ„¢ Enterprise announced on September 11, 2025, the stock experienced an overall decline. Initial rallies following these announcements, including a 42.72% surge on September 11, 2025, were not sustained, suggesting that underlying financial concerns or market skepticism outweighed the positive news over the longer term.
<br><br>
<b>5. Underlying Downtrend and Significant Volatility:</b>
The stock exhibited significant daily volatility, and despite intermittent upward movements, it was generally in a downtrend. While there were instances of the stock trending up, such as an 11.89% increase on December 19, 2025, following the launch of AI-Native NurseMagicâ„¢ EMR, the overall trend from August 31, 2025, to December 28, 2025, was negative, reflecting a challenging period for the company's stock performance.
Show moreStock Movement Drivers
Fundamental Drivers
The -32.7% change in AMST stock from 9/27/2025 to 12/27/2025 was primarily driven by a -67.6% change in the company's P/S Multiple.| 9272025 | 12272025 | Change | |
|---|---|---|---|
| Stock Price ($) | 3.15 | 2.12 | -32.70% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 0.08 | 0.19 | 134.43% |
| P/S Multiple | 154.74 | 50.10 | -67.63% |
| Shares Outstanding (Mil) | 4.05 | 4.57 | -12.77% |
| Cumulative Contribution | -33.80% |
Market Drivers
9/27/2025 to 12/27/2025| Return | Correlation | |
|---|---|---|
| AMST | -32.7% | |
| Market (SPY) | 4.3% | 38.2% |
| Sector (XLK) | 5.1% | 45.7% |
Fundamental Drivers
The -16.2% change in AMST stock from 6/28/2025 to 12/27/2025 was primarily driven by a -59.7% change in the company's P/S Multiple.| 6282025 | 12272025 | Change | |
|---|---|---|---|
| Stock Price ($) | 2.53 | 2.12 | -16.21% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 0.08 | 0.19 | 134.43% |
| P/S Multiple | 124.29 | 50.10 | -59.69% |
| Shares Outstanding (Mil) | 4.05 | 4.57 | -12.77% |
| Cumulative Contribution | -17.57% |
Market Drivers
6/28/2025 to 12/27/2025| Return | Correlation | |
|---|---|---|
| AMST | -16.2% | |
| Market (SPY) | 12.6% | 25.3% |
| Sector (XLK) | 17.0% | 23.3% |
Fundamental Drivers
The -57.4% change in AMST stock from 12/27/2024 to 12/27/2025 was primarily driven by a -68.9% change in the company's Shares Outstanding (Mil).| 12272024 | 12272025 | Change | |
|---|---|---|---|
| Stock Price ($) | 4.98 | 2.12 | -57.43% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 0.11 | 0.19 | 68.56% |
| P/S Multiple | 117.44 | 50.10 | -57.34% |
| Shares Outstanding (Mil) | 2.71 | 4.57 | -68.90% |
| Cumulative Contribution | -77.64% |
Market Drivers
12/27/2024 to 12/27/2025| Return | Correlation | |
|---|---|---|
| AMST | -57.4% | |
| Market (SPY) | 17.0% | 15.3% |
| Sector (XLK) | 24.0% | 14.5% |
Fundamental Drivers
The -7.0% change in AMST stock from 12/28/2022 to 12/27/2025 was primarily driven by a -100.1% change in the company's Shares Outstanding (Mil).| 12282022 | 12272025 | Change | |
|---|---|---|---|
| Stock Price ($) | 2.28 | 2.12 | -7.02% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 0.84 | 0.19 | -76.87% |
| P/S Multiple | 6.23 | 50.10 | 704.46% |
| Shares Outstanding (Mil) | 2.29 | 4.57 | -100.12% |
| Cumulative Contribution | -100.22% |
Market Drivers
12/28/2023 to 12/27/2025| Return | Correlation | |
|---|---|---|
| AMST | -19.1% | |
| Market (SPY) | 48.0% | 10.9% |
| Sector (XLK) | 53.5% | 11.2% |
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| AMST Return | -7% | -79% | -83% | 7% | 111% | -54% | -97% |
| Peers Return | 16% | 38% | -12% | 21% | 26% | 16% | 150% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 18% | 114% |
Monthly Win Rates [3] | |||||||
| AMST Win Rate | 50% | 17% | 25% | 42% | 58% | 42% | |
| Peers Win Rate | 52% | 65% | 42% | 68% | 57% | 52% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| AMST Max Drawdown | -22% | -80% | -83% | -16% | -16% | -58% | |
| Peers Max Drawdown | -34% | -5% | -26% | -7% | -9% | -23% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: HPQ, HPE, IBM, CSCO, AAPL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/26/2025 (YTD)
How Low Can It Go
| Event | AMST | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -98.3% | -25.4% |
| % Gain to Breakeven | 5662.7% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -22.6% | -33.9% |
| % Gain to Breakeven | 29.2% | 51.3% |
| Time to Breakeven | 36 days | 148 days |
Compare to HPQ, HPE, IBM, CSCO, AAPL
In The Past
Amesite's stock fell -98.3% during the 2022 Inflation Shock from a high on 2/19/2021. A -98.3% loss requires a 5662.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
AI Analysis | Feedback
- Amesite is the Shopify for online education, empowering organizations to create and manage their own AI-powered learning platforms.
- Amesite is an AI-powered Canvas or Blackboard for companies and universities.
AI Analysis | Feedback
- Amesite AI-Powered Learning Platform: A software-as-a-service (SaaS) platform that utilizes artificial intelligence to enable the rapid creation, delivery, and scaling of custom-branded online learning environments.
- Online Learning Program Development & Management: Services assisting universities and businesses in designing, deploying, and managing their online degree, certificate, and professional development programs on the Amesite platform.
AI Analysis | Feedback
Amesite (AMST) primarily sells its AI-powered online learning platform and services to other companies, educational institutions, and government agencies, operating in a Business-to-Business (B2B) model rather than directly to individuals.
Major customers include:
- Energy Transfer (NYSE: ET)
- Arizona State University (a major educational institution, not a public company)
AI Analysis | Feedback
- Amazon.com, Inc. (AMZN)
AI Analysis | Feedback
Ann Marie Sastry, Founder, CEO, and Chair, Amesite Inc. Board of Directors
Dr. Ann Marie Sastry founded Amesite to empower people with AI. She was previously CEO and co-Founder of Sakti3, a company recognized as one of MIT's 50 Smartest Companies in 2015. Sakti3 was acquired by Dyson in 2015 for $90 million. Prior to starting her companies, Dr. Sastry served as an Arthur F. Thurnau Professor at the University of Michigan for 17 years.
Sarah Berman, Principal Financial and Accounting Officer
Ms. Berman serves as Principal Financial and Accounting Officer at Amesite. She is a Certified Public Accountant with extensive experience in accounting, auditing, and record-keeping for both public and private companies. In June 2019, Ms. Berman founded her own firm, Better Books Consulting, to advise fast-growing clients.
Brandon Owens, Vice President of Sales
Mr. Owens brings deep experience in sales leadership, technology, and business to Amesite. Before joining Amesite, he worked at Pluralsight, where he generated significant new revenue, and was also the Director of Business Development at a healthcare analytics company. Early in his career, Mr. Owens worked for Corporate AT&T in its enterprise sales technology division.
AI Analysis | Feedback
Here are the key risks to Amesite (AMST) in order from most significant to less significant:- Inability to Achieve and Maintain Profitability and Going Concern Risk: Amesite has consistently reported significant losses and negative profit margins, indicating challenges in achieving sustainable profitability. The company has less than a year of cash runway, raising concerns about its ability to fund ongoing operations without securing additional capital. This situation presents a material risk to its ability to continue as a going concern.
- Shareholder Dilution: The company has experienced substantial shareholder dilution over the past year. This is highlighted as a significant risk, which can negatively impact the value of existing shares and investor confidence.
- Competition and Market Demand: Amesite faces risks related to intense competition within its market, including the presence of substitutes for its offerings. Furthermore, the company's business is subject to risks concerning the demand for its goods and services, which can be affected by factors such as seasonality and reliance on key customers.
AI Analysis | Feedback
The increasing likelihood of major hyperscale technology companies (such as Google, Microsoft, and Amazon) fully leveraging their extensive AI capabilities, cloud infrastructure, and existing customer bases to launch or significantly expand their own comprehensive, AI-native learning platforms that directly compete with Amesite's specialized offerings. These companies possess the resources to rapidly develop and market highly integrated solutions that could potentially offer greater scale, lower costs, and deeper ecosystem integration, posing a significant challenge to Amesite's market position.AI Analysis | Feedback
Amesite (NASDAQ: AMST) operates in several growing addressable markets for its AI-powered online learning platforms and content creation services, targeting businesses, K-12 education, and higher education, as well as the healthcare sector with its NurseMagicâ„¢ app. The addressable markets are sizable and demonstrate significant growth projections:
-
Global eLearning/Online Education Market:
- The global eLearning market is expected to reach approximately $203.81 billion in 2025 and is projected to grow to $279.30 billion by 2029.
- Other estimates for the global online education market include a valuation of USD 366.43 billion in 2024, with a projected CAGR of 20.4%. Another source valued it at USD 120 billion in 2024, anticipating a rise to USD 200 billion by 2031.
-
U.S. Online Learning Market:
- The U.S. online learning industry generated $100 billion in 2022 and is estimated to grow to nearly $687 billion by 2030.
- The U.S. is projected to generate nearly $99.84 billion in global eLearning revenue in 2025.
-
Global Corporate Training Market:
- This market was valued at $361.5 billion in 2023 and is estimated to reach $805.6 billion by 2035.
- Another report indicates the global corporate training market size was valued at USD 383.1 billion in 2023 and is expected to grow to USD 728.95 billion by 2032.
-
Global Corporate E-Learning Market:
- Estimates for this market vary significantly, with one source valuing it at USD 10.20 billion in 2025, projected to reach USD 14.63 billion by 2034. However, another source indicates a market size of USD 104.32 billion in 2024, projected to reach USD 334.96 billion by 2030. A higher estimate places the market at USD 519.45 billion in 2024, with a projection to reach USD 2018.75 billion by 2032.
-
Global Upskilling and Reskilling Market:
- This market reached USD 35.2 billion in 2024 and is forecasted to grow to USD 96.6 billion by 2033.
- In North America, the upskilling and reskilling market was valued at USD 13.2 billion in 2024.
-
Global Online Higher Education Market:
- The market size for global online higher education is estimated to be approximately $150 billion in 2024.
- The U.S. online university education market alone is projected to reach $94 billion in 2025.
-
Global AI in Education Market:
- The AI in education market is projected to reach $5.02 billion by 2033.
AI Analysis | Feedback
Amesite (NASDAQ: AMST) is positioned for future revenue growth over the next 2-3 years, driven by several strategic initiatives and product advancements:
- Expansion and Adoption of NurseMagicâ„¢: The company's flagship product, NurseMagicâ„¢, is a primary driver of revenue growth. It has demonstrated exceptional market performance and is credited with significant revenue gains. Amesite has also launched a census-based enterprise tier for NurseMagicâ„¢ to further expand its total addressable market and address enterprise demand, alongside continuously improving customer adoption in post-acute healthcare settings.
- Shift Towards Enterprise B2B Sales: Amesite is strategically focusing on a more profitable business-to-business (B2B) strategy, moving away from its B2C segment. This includes the introduction of an innovative AI tool designed to streamline complex government form submissions, which is expected to bolster enterprise sales. The company is actively expanding its customer base and offerings within the post-acute healthcare business sector across the U.S.
- Launch of AI-Powered Electronic Medical Record (EMR): A significant future growth driver is Amesite's ambition to launch what it intends to be the industry's first AI-powered Electronic Medical Record (EMR) platform specifically for post-acute care by 2026. This initiative is expected to optimize operational efficiencies within one of the fastest-growing healthcare segments and represents a commitment to continuous AI-driven product innovation.
- International Growth and Multi-Language Support: The NurseMagicâ„¢ app currently supports operations in 16 languages, extending its reach to nearly one million U.S. nurses. Furthermore, the platform serves B2B and B2C users in 21 countries and offers translations into over 50 languages, indicating a foundation for continued customer growth through broader accessibility and international market penetration.
AI Analysis | Feedback
Share Issuance
- In February 2022, Amesite increased a public offering of common stock to 3,750,000 shares at $0.80 per share, aiming to raise approximately $3 million for general corporate activities, including capital expenditures and working capital.
- In January 2025, Amesite priced a public offering of 1,201,667 shares of common stock at $3.00 per share, for an aggregate offering of approximately $3.6 million.
- As of June 30, 2025, the number of shares outstanding was 4,572,713, reflecting an increase from 2,542,440 shares a year prior due to recent equity issuances.
Inbound Investments
- In January 2025, certain officers and directors of Amesite participated in a public offering, subscribing for approximately $1.26 million of the company's common stock.
Capital Expenditures
- Amesite intends to use the net proceeds from both its February 2022 and January 2025 public offerings for general corporate purposes, including capital expenditures and working capital.
- The company's reported Capital Expenditures are approximately $0.3176.
- The primary focus of capital allocation is on enhancing its AI platform and products, such as its flagship NurseMagicâ„¢ offering for online learning solutions in the healthcare market.
Latest Trefis Analyses
| Title | Topic | |
|---|---|---|
| DASHBOARDS | ||
| Amesite Earnings Notes | ||
| Can Amesite Stock Hold Up When Markets Turn? | Return |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to AMST. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11302025 | ENPH | Enphase Energy | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 14.4% | 14.4% | -0.9% |
| 11262025 | PD | PagerDuty | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 13.1% | 13.1% | 0.0% |
| 11212025 | CRM | Salesforce | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 17.3% | 17.3% | -0.1% |
| 11212025 | HUBS | HubSpot | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 12.0% | 12.0% | 0.0% |
| 11212025 | FIVN | Five9 | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 5.5% | 5.5% | 0.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Amesite
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 51.32 |
| Mkt Cap | 158.8 |
| Rev LTM | 56,496 |
| Op Inc LTM | 7,584 |
| FCF LTM | 7,327 |
| FCF 3Y Avg | 7,366 |
| CFO LTM | 8,590 |
| CFO 3Y Avg | 8,697 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 7.4% |
| Rev Chg 3Y Avg | 2.2% |
| Rev Chg Q | 9.4% |
| QoQ Delta Rev Chg LTM | 2.1% |
| Op Mgn LTM | 12.1% |
| Op Mgn 3Y Avg | 11.9% |
| QoQ Delta Op Mgn LTM | 0.2% |
| CFO/Rev LTM | 14.6% |
| CFO/Rev 3Y Avg | 17.1% |
| FCF/Rev LTM | 11.6% |
| FCF/Rev 3Y Avg | 12.1% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Direct-to-practitioner (B2C) and enterprise (B2B) artificial intelligence (AI)-driven solutions | 0 | ||||
| Single Segment | 1 | 1 | 1 | 0 | |
| Total | 0 | 1 | 1 | 1 | 0 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Direct-to-practitioner (B2C) and enterprise (B2B) artificial intelligence (AI)-driven solutions | -4 | ||||
| Total | -4 |
Price Behavior
| Market Price | $2.12 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 09/25/2020 | |
| Distance from 52W High | -57.5% | |
| 50 Days | 200 Days | |
| DMA Price | $2.75 | $2.78 |
| DMA Trend | down | down |
| Distance from DMA | -23.0% | -23.6% |
| 3M | 1YR | |
| Volatility | 73.1% | 104.2% |
| Downside Capture | 323.64 | 221.18 |
| Upside Capture | 69.59 | 102.34 |
| Correlation (SPY) | 37.9% | 14.8% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 2.68 | 2.48 | 2.99 | 2.01 | 0.73 | 0.87 |
| Up Beta | 3.31 | 3.52 | 5.35 | 2.37 | 0.19 | 0.29 |
| Down Beta | 2.89 | 2.19 | 1.91 | 1.36 | 0.64 | 1.06 |
| Up Capture | -105% | 101% | 188% | 155% | 131% | 93% |
| Bmk +ve Days | 12 | 25 | 38 | 73 | 141 | 426 |
| Stock +ve Days | 3 | 12 | 21 | 53 | 106 | 335 |
| Down Capture | 414% | 287% | 288% | 229% | 122% | 107% |
| Bmk -ve Days | 7 | 16 | 24 | 52 | 107 | 323 |
| Stock -ve Days | 14 | 25 | 37 | 65 | 131 | 398 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Comparison of AMST With Other Asset Classes (Last 1Y) | |||||||
|---|---|---|---|---|---|---|---|
| AMST | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -58.5% | 25.0% | 17.8% | 72.1% | 8.6% | 4.4% | -8.2% |
| Annualized Volatility | 103.6% | 27.5% | 19.4% | 19.3% | 15.2% | 17.0% | 35.0% |
| Sharpe Ratio | -0.41 | 0.79 | 0.72 | 2.70 | 0.34 | 0.09 | -0.08 |
| Correlation With Other Assets | 13.9% | 14.6% | -3.4% | 9.4% | 13.8% | 20.8% | |
ETFs used for asset classes: Sector ETF = XLK, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Comparison of AMST With Other Asset Classes (Last 5Y) | |||||||
|---|---|---|---|---|---|---|---|
| AMST | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -49.5% | 18.8% | 14.7% | 18.7% | 11.5% | 4.6% | 30.8% |
| Annualized Volatility | 122.9% | 24.7% | 17.1% | 15.5% | 18.7% | 18.9% | 48.6% |
| Sharpe Ratio | -0.01 | 0.69 | 0.70 | 0.97 | 0.50 | 0.16 | 0.57 |
| Correlation With Other Assets | 10.6% | 12.1% | 0.4% | 7.4% | 7.7% | 9.9% | |
ETFs used for asset classes: Sector ETF = XLK, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Comparison of AMST With Other Asset Classes (Last 10Y) | |||||||
|---|---|---|---|---|---|---|---|
| AMST | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -47.7% | 22.5% | 14.8% | 15.3% | 7.0% | 5.3% | 69.2% |
| Annualized Volatility | 121.2% | 24.2% | 18.0% | 14.7% | 17.6% | 20.8% | 55.8% |
| Sharpe Ratio | 0.00 | 0.85 | 0.71 | 0.86 | 0.32 | 0.22 | 0.90 |
| Correlation With Other Assets | 10.2% | 11.8% | 0.6% | 7.3% | 7.7% | 9.9% | |
ETFs used for asset classes: Sector ETF = XLK, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 5/16/2025 | -9.8% | -13.1% | -15.2% |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 1 | 1 | 1 |
| Median Positive | |||
| Median Negative | -9.8% | -13.1% | -15.2% |
| Max Positive | |||
| Max Negative | -9.8% | -13.1% | -15.2% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 10242025 | 10-Q 9/30/2025 |
| 6302025 | 9292025 | 10-K 6/30/2025 |
| 3312025 | 5152025 | 10-Q 3/31/2025 |
| 12312024 | 2072025 | 10-Q 12/31/2024 |
| 9302024 | 11142024 | 10-Q 9/30/2024 |
| 6302024 | 9302024 | 10-K 6/30/2024 |
| 3312024 | 5102024 | 10-Q 3/31/2024 |
| 12312023 | 2142024 | 10-Q 12/31/2023 |
| 9302023 | 11132023 | 10-Q 9/30/2023 |
| 6302023 | 10062023 | 10-K 6/30/2023 |
| 3312023 | 5152023 | 10-Q 3/31/2023 |
| 12312022 | 2172023 | 10-Q 12/31/2022 |
| 9302022 | 11102022 | 10-Q 9/30/2022 |
| 6302022 | 9282022 | 10-K 6/30/2022 |
| 3312022 | 5132022 | 10-Q 3/31/2022 |
| 12312021 | 2182022 | 10-Q 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.